Literature DB >> 12099702

Gene silencing in mammalian cells by preformed small RNA duplexes.

Marianne Leirdal1, Mouldy Sioud.   

Abstract

Small interfering RNAs (siRNAs) mediate RNA interference (RNAi), a process in which target mRNAs are degraded. Here, we have investigated the efficacy of preformed siRNAs to modulate the expression of protein kinase Calpha (PKCalpha) and green fluorescent protein (GFP) in mammalian cells. We show that specific inhibition of PKCalpha and GFP can be achieved by in vitro transcribed siRNAs. Interestingly, a transcript harboring two self-complementary siRNAs interrupted by a single-stranded loop region inhibited both PKCalpha and GFP gene expression. These results suggest that the long transcript is processed by single-stranded ribonucleases and/or other proteins into two functional siRNAs. Incubation of the in vitro transcribed bispecific siRNA with protein extracts from HEK 293T cells yielded RNA duplexes similar to the synthetic single siRNA. Taken together, the present data indicate that in vitro transcribed siRNA can be useful for silencing gene expression. Additionally, bi- and perhaps poly-siRNAs may be expressed and processed in mammalian cells. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12099702     DOI: 10.1016/s0006-291x(02)00736-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  A novel approach for evaluating the efficiency of siRNAs on protein levels in cultured cells.

Authors:  Weilin Wu; Emily Hodges; Jenny Redelius; Christer Höög
Journal:  Nucleic Acids Res       Date:  2004-01-22       Impact factor: 16.971

Review 2.  RNA interference: the molecular immune system.

Authors:  Omar Bagasra; Kiley R Prilliman
Journal:  J Mol Histol       Date:  2004-08       Impact factor: 2.611

3.  Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape.

Authors:  Joshua N Leonard; David V Schaffer
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Vaccinia virus intermediate and late promoter elements are targeted by the TATA-binding protein.

Authors:  Bruce A Knutson; Xu Liu; Jaewook Oh; Steven S Broyles
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Ras-association domain family 1 protein, RASSF1C, is an IGFBP-5 binding partner and a potential regulator of osteoblast cell proliferation.

Authors:  Yousef G Amaar; David J Baylink; Subburaman Mohan
Journal:  J Bone Miner Res       Date:  2005-03-14       Impact factor: 6.741

6.  Effective siRNA targets screening for human telomerase reverse transcriptase.

Authors:  Yun Xia; Ru-Xian Lin; Su-Jun Zheng; Ying Yang; Xiao-Chen Bo; Dao-Yin Zhu; Sheng-Qi Wang
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

7.  Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction.

Authors:  Inthirai Somasuntharam; Archana V Boopathy; Raffay S Khan; Mario D Martinez; Milton E Brown; Niren Murthy; Michael E Davis
Journal:  Biomaterials       Date:  2013-07-13       Impact factor: 12.479

8.  HIV evades RNA interference directed at TAR by an indirect compensatory mechanism.

Authors:  Joshua N Leonard; Priya S Shah; John C Burnett; David V Schaffer
Journal:  Cell Host Microbe       Date:  2008-11-13       Impact factor: 21.023

9.  Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors.

Authors:  Sheena Saayman; Patrick Arbuthnot; Marc S Weinberg
Journal:  Nucleic Acids Res       Date:  2010-06-04       Impact factor: 16.971

10.  NG2, a novel proapoptotic receptor, opposes integrin alpha4 to mediate anoikis through PKCalpha-dependent suppression of FAK phosphorylation.

Authors:  N E Joo; T Watanabe; C Chen; M Chekenya; W B Stallcup; Y L Kapila
Journal:  Cell Death Differ       Date:  2008-02-22       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.